[go: up one dir, main page]

MX2016011177A - Anticuerpos a la metaloproteinasa de matriz 9 y metodos de uso de los mismos. - Google Patents

Anticuerpos a la metaloproteinasa de matriz 9 y metodos de uso de los mismos.

Info

Publication number
MX2016011177A
MX2016011177A MX2016011177A MX2016011177A MX2016011177A MX 2016011177 A MX2016011177 A MX 2016011177A MX 2016011177 A MX2016011177 A MX 2016011177A MX 2016011177 A MX2016011177 A MX 2016011177A MX 2016011177 A MX2016011177 A MX 2016011177A
Authority
MX
Mexico
Prior art keywords
antibodies
methods
matrix metalloproteinase
mmp9
functional fragment
Prior art date
Application number
MX2016011177A
Other languages
English (en)
Inventor
Smith Victoria
Vaysberg Maria
L Gossage David
Haw- Ling Lin Joseph
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc
Publication of MX2016011177A publication Critical patent/MX2016011177A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/567—Framework region [FR]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente descripción proporciona composiciones y métodos de uso que involucran las proteínas de unión, por ejemplo, anticuerpos y fragmentos de unión a antígeno de los mismos que se unen a la proteína de metaloproteinasa de matriz 9 (MMP9) (MMP9 también es conocida como gelatinasa-B), tal como en donde las proteínas de unión comprenden una cadena pesada de inmunoglobulina (lg) (o fragmento funcional de la misma) y una cadena ligera de lg (o fragmento funcional de la misma).
MX2016011177A 2014-02-27 2015-02-25 Anticuerpos a la metaloproteinasa de matriz 9 y metodos de uso de los mismos. MX2016011177A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461945737P 2014-02-27 2014-02-27
PCT/US2015/017562 WO2015130813A1 (en) 2014-02-27 2015-02-25 Antibodies to matrix metalloproteinase 9 and methods of use thereof

Publications (1)

Publication Number Publication Date
MX2016011177A true MX2016011177A (es) 2016-12-16

Family

ID=52672334

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016011177A MX2016011177A (es) 2014-02-27 2015-02-25 Anticuerpos a la metaloproteinasa de matriz 9 y metodos de uso de los mismos.

Country Status (13)

Country Link
US (1) US20150239988A1 (es)
EP (1) EP3110847A1 (es)
JP (1) JP2017507949A (es)
KR (1) KR20160125466A (es)
CN (1) CN106062001A (es)
AR (1) AR099604A1 (es)
AU (1) AU2015223139A1 (es)
CA (1) CA2940869A1 (es)
EA (1) EA201691414A1 (es)
MX (1) MX2016011177A (es)
SG (1) SG11201606546VA (es)
TW (1) TW201544511A (es)
WO (1) WO2015130813A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10941178B2 (en) 2017-03-17 2021-03-09 Gilead Sciences, Inc. Method of purifying an antibody
US11000538B2 (en) * 2018-10-31 2021-05-11 Amorepacific Corporation Composition for enhancing exercise ability or anti-fatigue comprising novel ginsenoside
WO2023278491A1 (en) * 2021-06-28 2023-01-05 Releviate, Llc Mmp-9 antibodies and uses thereof
WO2025264572A1 (en) 2024-06-17 2025-12-26 Alector Llc Transferrin receptor antigen-binding domains and uses therefor
CN119060188B (zh) * 2024-08-30 2025-09-12 武汉爱博泰克生物科技有限公司 抗人基质金属蛋白酶9抗体、抗体对和检测试剂盒

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
DK0814159T3 (da) 1990-08-29 2005-10-24 Genpharm Int Transgene, ikke-humane dyr, der er i stand til at danne heterologe antistoffer
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
GB9022788D0 (en) 1990-10-19 1990-12-05 Cortecs Ltd Pharmaceutical formulations
WO1993011161A1 (en) 1991-11-25 1993-06-10 Enzon, Inc. Multivalent antigen-binding proteins
WO2002066057A2 (en) * 2001-02-23 2002-08-29 Biophage Inc. Methods and compositions for preventing and treating neutrophil-mediated diseases
EP2262529A4 (en) * 2008-03-03 2013-05-08 Dyax Corp METALLOPROTEINASE BINDING PROTEINS 9
US9550836B2 (en) * 2012-02-29 2017-01-24 Gilead Biologics, Inc. Method of detecting human matrix metalloproteinase 9 using antibodies
HK1204926A1 (en) * 2012-02-29 2015-12-11 吉联亚生物科技有限公司 Antibodies to matrix metalloproteinase 9

Also Published As

Publication number Publication date
EP3110847A1 (en) 2017-01-04
KR20160125466A (ko) 2016-10-31
CN106062001A (zh) 2016-10-26
CA2940869A1 (en) 2015-09-03
US20150239988A1 (en) 2015-08-27
SG11201606546VA (en) 2016-09-29
AU2015223139A1 (en) 2016-08-25
EA201691414A1 (ru) 2017-03-31
AR099604A1 (es) 2016-08-03
JP2017507949A (ja) 2017-03-23
TW201544511A (zh) 2015-12-01
WO2015130813A1 (en) 2015-09-03

Similar Documents

Publication Publication Date Title
MX2018007630A (es) Anticuerpos contra la metaloproteinasa de matriz 9.
PH12016501691A1 (en) Antibodies to matrix metalloproteinase 9
PH12014501931A1 (en) Antibodies to matrix metalloproteinase 9
PH12018502478A1 (en) Bispecific binding proteins binding an immunomodulatory protein and a tumor antigen
EA201791961A1 (ru) Антитела, специфичные к cd47 и pd-l1
BR112018067458A2 (pt) anticorpos para tigit
EA201591153A1 (ru) Антитела, связывающиеся с tl1a, и их применение
AR105267A1 (es) Anticuerpos de unión a tau
JOP20160131B1 (ar) الأجسام المضادة للعامل xi وطرق الاستخدام
BR112018012352A2 (pt) anticorpos anti-lag3 e fragmentos de ligação ao antígeno
EA201890285A1 (ru) Антитела против pd-1, активируемые антитела против pd-1 и способы их применения
MX2022010487A (es) Anticuerpos anti-axl, fragmentos de anticuerpos y sus inmunoconjugados y usos de los mismos.
EA201791666A1 (ru) Антитела к cd3, антитела к cd123 и биспецифические антитела, которые специфически связываются с cd3 и/или cd123
PE20150023A1 (es) Proteinas de union a antigeno st2
EA201891709A1 (ru) Антигенсвязывающие белки, связывающие pd-l1
EA201792221A1 (ru) Антитела против сортилина и способы их применения
EA201692394A1 (ru) Антитела и антигенсвязывающие фрагменты, которые специфично связываются с белком тау, ассоциированным с микротрубочками
EA202090559A1 (ru) Мультиспецифические антитела, специфичные в отношении эпитопов вируса зика, и их применение
EA202091350A1 (ru) Связывающие молекулы, специфично связывающиеся с тау-белком
EA201992281A1 (ru) Связывающие молекулы, специфично связывающиеся с тау-белком
MX2022009915A (es) Anticuerpos anti-ror2, fragmentos de anticuerpos, sus inmunoconjugados y usos de los mismos.
EA201791691A1 (ru) ОДНОДОМЕННЫЕ АНТИТЕЛА, НАПРАВЛЕННЫЕ НА CD1d
EA201790816A1 (ru) Антитела, которые связываются с ccr6, и варианты применения указанных антител
EA201990895A1 (ru) Антитела к о1 и варианты их применения
MX2016011177A (es) Anticuerpos a la metaloproteinasa de matriz 9 y metodos de uso de los mismos.